Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab
Wakelee, H.A, Dahlberg, S.E, Brahmer, J.R, Schiller, J.H, Perry, M.C, Langer, C.J, Sandler, A.B, Belani, C.P, Johnson, D.H
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2012)
Get full text
Journal Article
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia
DeAngelo, D J, Stevenson, K E, Dahlberg, S E, Silverman, L B, Couban, S, Supko, J G, Amrein, P C, Ballen, K K, Seftel, M D, Turner, A R, Leber, B, Howson-Jan, K, Kelly, K, Cohen, S, Matthews, J H, Savoie, L, Wadleigh, M, Sirulnik, L A, Galinsky, I, Neuberg, D S, Sallan, S E, Stone, R M
Published in Leukemia (01.03.2015)
Published in Leukemia (01.03.2015)
Get full text
Journal Article
SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15
Tessema, M, Yingling, C M, Thomas, C L, Klinge, D M, Bernauer, A M, Liu, Y, Dacic, S, Siegfried, J M, Dahlberg, S E, Schiller, J H, Belinsky, S A
Published in Oncogene (13.09.2012)
Published in Oncogene (13.09.2012)
Get full text
Journal Article